Go to Advanced Search
MSE developed world’s first nanomedicine for glaucoma patients with Singapore Eye Research Institute (SERI).
MSE's biomedical start-up, Amaranth Medical Pte Ltd, which manufactures fully bio-absorbable stents, received Series C funding from Boston Scientific, a global medical devices manufacturer and the leader in coronary stenting.
MSE launched the Ma Jan Memorial Fund in memory of Professor Ma Jan’s (Chair of MSE, 2011-2012) dedication and contribution to education.
MSE’s breakthrough in solar technology was reported in top journal, Science and featured in media.
MSE launched the Ocular Therapeutic Engineering Centre (OTEC), which focuses on ocular research work, building on the strong research collaboration between clinical scientists and NTU technologists, to develop new drug delivery systems for the eye.
MSE’s collaboration with the Singapore Eye Research Institute (SERI) led to the development of a post-surgical gel to help prevent scarring in the eyes of glaucoma patients.
MSE’s breakthrough research on damage-tolerant biological composites was reported in top journal, Science and featured in media.
MSE and ERI@N launched NTU’s Solar Fuels Lab – Asia’s first – which aims to create efficient and sustainable sources of hydrogen fuel from water by developing an “artificial leaf” device.
MSE became the first institution in Singapore to have won three CRP grants since 2008.
NTU and Linköping University set up a new research centre Biomimetic Sensor Science.
NTU collaborates with Bosch in organic photovoltaics research.
MSE’s biomedical start-up, Amaranth Medical Pte Ltd, received US$7.5m in funding from Silicon Valley venture capitalist, Charter Life Sciences and EDB’s Bio*One Capital.
MSE’s first joint venture medical device, Ree-Trakt was released for sale in the United States.
MSE signed MOU with the renowned Mayo Clinic in USA to conduct joint research in alternative cancer therapy.
MSE partnered the Eye Institute at Tan Tock Seng Hospital to develop a revolutionary method of cataract removal.
The School of Materials Engineering was renamed as School of Materials Science and Engineering (MSE).
MSE signed MOU with National Heart Centre to develop cardiovascular devices.
SME’s invention of the world’s first completely-dissolving heart stent was a biomedical treatment breakthrough.
The Division of Materials Engineering was elevated into a full-fledged engineering school - School of Materials Engineering (SME).
The 4-year direct honours programme leading to the Bachelor of Engineering (Materials Engineering) was introduced.
The Division of Materials Engineering was first established under the School of Applied Science, offering a 3-year programme leading to the Bachelor of Applied Science (Materials Engineering) degree. An optional 4-year programme leading to the Bachelor of Applied Science with honours was also available.
Data Protection and Privacy
Reg. No. 200604393R
© 2012 Nanyang Technological University
Last modified on